-
1
-
-
0024428817
-
Medical uses of mylabris in ancient China and recent studies
-
Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol. 1989;26(2):147-162.
-
(1989)
J Ethnopharmacol.
, vol.26
, Issue.2
, pp. 147-162
-
-
Wang, G.S.1
-
3
-
-
0029034492
-
Effects of norcantharidin, a protein phosphatase type-2 A inhibitor, on the growth of normal and malignant haemopoietic cells
-
Liu XH, Blazsek I, Comisso M, et al. Effects of norcantharidin, a protein phosphatase type-2 A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur J Cancer. 1995;31(6):953-963.
-
(1995)
Eur J Cancer.
, vol.31
, Issue.6
, pp. 953-963
-
-
Liu, X.H.1
Blazsek, I.2
Comisso, M.3
-
4
-
-
64749109218
-
Poly(lactide-co-glycolide) nanoparticles as carriers for norcantharidin
-
Zeng QB, Sun M. Poly(lactide-co-glycolide) nanoparticles as carriers for norcantharidin. Mater Sci Eng C. 2009;29(3):708-713.
-
(2009)
Mater Sci Eng C.
, vol.29
, Issue.3
, pp. 708-713
-
-
Zeng, Q.B.1
Sun, M.2
-
5
-
-
34447635904
-
Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation
-
Hill TA, Stewart SG, Ackland SP, et al. Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation. Bioorg Med Chem. 2007;15(18): 6126-6134.
-
(2007)
Bioorg Med Chem.
, vol.15
, Issue.18
, pp. 6126-6134
-
-
Hill, T.A.1
Stewart, S.G.2
Ackland, S.P.3
-
6
-
-
33748685215
-
A less irritant norcantharidin lipid microspheres: Formulation and drug distribution
-
Wang LX, He HB, Tang X, Shao RY, Chen DW. A less irritant norcantharidin lipid microspheres: formulation and drug distribution. Int J Pharm. 2006;323:161-167.
-
(2006)
Int J Pharm.
, vol.323
, pp. 161-167
-
-
Wang, L.X.1
He, H.B.2
Tang, X.3
Shao, R.Y.4
Chen, D.W.5
-
7
-
-
67651227161
-
Application of targeted drug delivery system in Chinese medicine
-
Li DC, Zhong XK, Zeng ZP, Jiang JG, et al. Application of targeted drug delivery system in Chinese medicine. J Control Release. 2009;138(2): 103-112.
-
(2009)
J Control Release.
, vol.138
, Issue.2
, pp. 103-112
-
-
Li, D.C.1
Zhong, X.K.2
Zeng, Z.P.3
Jiang, J.G.4
-
8
-
-
79951675295
-
In vitro characterization, and in vivo studies of crosslinked lactosaminated carboxymethyl chitosan nanoparticles
-
Zheng H, Zhang XQ, Yin YH, et al. In vitro characterization, and in vivo studies of crosslinked lactosaminated carboxymethyl chitosan nanoparticles. Carbohydr Polym. 2011;84(3):1048-1053.
-
(2011)
Carbohydr Polym.
, vol.84
, Issue.3
, pp. 1048-1053
-
-
Zheng, H.1
Zhang, X.Q.2
Yin, Y.H.3
-
9
-
-
33751224468
-
Novel polymeric microspheres containing norcantharidin for chemoembolization
-
Liu XH, Heng WS, Paul, LQ, Chan LW. Novel polymeric microspheres containing norcantharidin for chemoembolization. J Control Release. 2006;116:35-41.
-
(2006)
J Control Release.
, vol.116
, pp. 35-41
-
-
Liu, X.H.1
Heng, W.S.2
Paul, L.Q.3
Chan, L.W.4
-
10
-
-
0035936972
-
Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency
-
Mao HQ, Roy KN, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70(3):399-421.
-
(2001)
J Control Release.
, vol.70
, Issue.3
, pp. 399-421
-
-
Mao, H.Q.1
Roy, K.N.2
Troung-le, V.L.3
-
11
-
-
77249111686
-
The safety of chitosan as a pharmaceutical excipient
-
Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharm. 2010;56(3):290-299.
-
(2010)
Regul Toxicol Pharm.
, vol.56
, Issue.3
, pp. 290-299
-
-
Baldrick, P.1
-
12
-
-
79952444444
-
Effect of PVP-coated silver nanoparticles using laser direct patterning process by photothermal effect
-
Cheng YT, Uang RH, Chiou KC. Effect of PVP-coated silver nanoparticles using laser direct patterning process by photothermal effect. Microelectron Eng. 2011;88(6):929-934.
-
(2011)
Microelectron Eng.
, vol.88
, Issue.6
, pp. 929-934
-
-
Cheng, Y.T.1
Uang, R.H.2
Chiou, K.C.3
-
14
-
-
77955417131
-
Gas chromatography/mass spectrometry (GC/MS) remains a preeminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry(LC/MS/MS)
-
Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH. Gas chromatography/mass spectrometry (GC/MS) remains a preeminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry(LC/MS/MS). J Steroid Biochem Mol Biol. 2010;121:496-504.
-
(2010)
J Steroid Biochem Mol Biol.
, vol.121
, pp. 496-504
-
-
Krone, N.1
Hughes, B.A.2
Lavery, G.G.3
Stewart, P.M.4
Arlt, W.5
Shackleton, C.H.6
-
15
-
-
11144317888
-
Chemical fingerprint and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods
-
Zhang JL, Cui M, He Y, Yu HL, Guo DA. Chemical fingerprint and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods. J Pharm Biomed Anal. 2005;36(5): 1029-1035.
-
(2005)
J Pharm Biomed Anal.
, vol.36
, Issue.5
, pp. 1029-1035
-
-
Zhang, J.L.1
Cui, M.2
He, Y.3
Yu, H.L.4
Guo, D.A.5
-
16
-
-
0036470424
-
Complete sequencing of anti-vancomycin fab fragment by liquid chromatography-electrospray ion trap mass spectrometry with a combination of database searching and manual interpretation of the MS/MS spectra
-
Adamczyk M, Gebler JC, Wu J, Yu ZG. Complete sequencing of anti-vancomycin fab fragment by liquid chromatography-electrospray ion trap mass spectrometry with a combination of database searching and manual interpretation of the MS/MS spectra. J Immunol Meth. 2002;260:235-249.
-
(2002)
J Immunol Meth.
, vol.260
, pp. 235-249
-
-
Adamczyk, M.1
Gebler, J.C.2
Wu, J.3
Yu, Z.G.4
-
17
-
-
42649083309
-
High performance liquid chromatography-mass spectrometry analysis for rat metabolism and pharmacokinetic studies of lithospermic acid B from danshen
-
Cui L, Chan W, Wu JL, Jiang ZH, Chan K, Cai ZW. High performance liquid chromatography-mass spectrometry analysis for rat metabolism and pharmacokinetic studies of lithospermic acid B from danshen. Talanta. 2008;75:1002-1007.
-
(2008)
Talanta.
, vol.75
, pp. 1002-1007
-
-
Cui, L.1
Chan, W.2
Wu, J.L.3
Jiang, Z.H.4
Chan, K.5
Cai, Z.W.6
-
18
-
-
38349137338
-
Pharmacokinetics and metabolism of lithospermic acid by LC-MS/MS in rats
-
Wang L, Zhang Q, Li XC, et al. Pharmacokinetics and metabolism of lithospermic acid by LC-MS/MS in rats. Int J Pharm. 2008;350: 240-246.
-
(2008)
Int J Pharm.
, vol.350
, pp. 240-246
-
-
Wang, L.1
Zhang, Q.2
Li, X.C.3
-
19
-
-
0030779190
-
Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
-
Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14:1431-1436.
-
(1997)
Pharm Res.
, vol.14
, pp. 1431-1436
-
-
Calvo, P.1
Remunan-Lopez, C.2
Vila-Jato, J.L.3
Alonso, M.J.4
-
20
-
-
77949916194
-
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery
-
Wang Q, Zhang L, Hu W, et al. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomed Nanotechnol Biol Med. 2010;6:371-381.
-
(2010)
Nanomed Nanotechnol Biol Med.
, vol.6
, pp. 371-381
-
-
Wang, Q.1
Zhang, L.2
Hu, W.3
-
21
-
-
77954287550
-
Two modelling data analytical methods applied to optimise the preparation of norcantharidin chitosan nanoparticles
-
Zhang W, Liu Y, Chen XY, et al. Two modelling data analytical methods applied to optimise the preparation of norcantharidin chitosan nanoparticles. J Exp Nanosci. 2010;5(3):271-284.
-
(2010)
J Exp Nanosci.
, vol.5
, Issue.3
, pp. 271-284
-
-
Zhang, W.1
Liu, Y.2
Chen, X.Y.3
-
22
-
-
79953084395
-
Absorption, distribution, metabolism, and excretion of [1-14C]-perfluorohexanoate ([14C]-PFHx) in rats and mice
-
Gannon SA, Johnson T, Nabb DL, Serex TL, Buck RC, Loveless SE. Absorption, distribution, metabolism, and excretion of [1-14C]-perfluorohexanoate ([14C]-PFHx) in rats and mice. Toxicology. 2011;283:55-62.
-
(2011)
Toxicology.
, vol.283
, pp. 55-62
-
-
Gannon, S.A.1
Johnson, T.2
Nabb, D.L.3
Serex, T.L.4
Buck, R.C.5
Loveless, S.E.6
-
23
-
-
0034608989
-
Pharmacokinetics, tissue distribution, and metabolism of flumequine in channel catfish (Ictalurus punctatus)
-
Plakas SM, Said KR, Musser SM. Pharmacokinetics, tissue distribution, and metabolism of flumequine in channel catfish (Ictalurus punctatus). Aquaculture. 2000;187:1-14.
-
(2000)
Aquaculture.
, vol.187
, pp. 1-14
-
-
Plakas, S.M.1
Said, K.R.2
Musser, S.M.3
-
24
-
-
77649236913
-
Chitosan filler effects on the experimental characterization, spectroscopic investigation and thermal studies of PVA/PVP blend films
-
Abdelrazek EM, Elashmawi IS, Labeeb S. Chitosan filler effects on the experimental characterization, spectroscopic investigation and thermal studies of PVA/PVP blend films. Physica B. 2010;405(8): 2021-2027.
-
(2010)
Physica B.
, vol.405
, Issue.8
, pp. 2021-2027
-
-
Abdelrazek, E.M.1
Elashmawi, I.S.2
Labeeb, S.3
-
25
-
-
33750311400
-
2 submicron particles via microwave irradiation
-
2 submicron particles via microwave irradiation. Mater Lett. 2006;60: 3714-3717.
-
(2006)
Mater Lett.
, vol.60
, pp. 3714-3717
-
-
Yang, H.M.1
Huang, C.H.2
Su, X.H.3
-
26
-
-
10644232971
-
Studies on the liver targeting of norcantharindin microemulsion
-
Zhang L, Xiang D, Zheng H, Zhang ZR. Studies on the liver targeting of norcantharindin microemulsion. Acta Pharmaceutica Sinica. 2004;39(8):650-655.
-
(2004)
Acta Pharmaceutica Sinica.
, vol.39
, Issue.8
, pp. 650-655
-
-
Zhang, L.1
Xiang, D.2
Zheng, H.3
Zhang, Z.R.4
-
27
-
-
68449098284
-
Pharmacokinetics of norcantharidin in human by urinary excretion method
-
Wei CM, Wang BJ, Yuan GY. Pharmacokinetics of norcantharidin in human by urinary excretion method. Chin Pharm J. 2009;44: 1019-1021.
-
(2009)
Chin Pharm J.
, vol.44
, pp. 1019-1021
-
-
Wei, C.M.1
Wang, B.J.2
Yuan, G.Y.3
-
28
-
-
77950933847
-
Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry
-
Fang ZG, You BG, Chen YG, et al. Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2010;878:1153-1162.
-
(2010)
J Chromatogr B.
, vol.878
, pp. 1153-1162
-
-
Fang, Z.G.1
You, B.G.2
Chen, Y.G.3
-
29
-
-
79957843199
-
Separation and identification of norcantharidin metabolites in vivo by GC-method
-
Wei CM, Teng YN, Wang BJ, et al. Separation and identification of norcantharidin metabolites in vivo by GC-method. J Chromatogr B. 2011;879:1741-1747.
-
(2011)
J Chromatogr B.
, vol.879
, pp. 1741-1747
-
-
Wei, C.M.1
Teng, Y.N.2
Wang, B.J.3
-
31
-
-
21744446564
-
Preparation of nanoparticles composed of poly (s-glutamic acid)-poly (lactide) block copolymers and evaluation of their uptake by HepG2 cells
-
Liang HF, Yang TF, Huang CT, Chen MC, Sung HW. Preparation of nanoparticles composed of poly (s-glutamic acid)-poly (lactide) block copolymers and evaluation of their uptake by HepG2 cells. J Control Release. 2005;105:213-225.
-
(2005)
J Control Release.
, vol.105
, pp. 213-225
-
-
Liang, H.F.1
Yang, T.F.2
Huang, C.T.3
Chen, M.C.4
Sung, H.W.5
-
32
-
-
3042697876
-
177 Polycationic liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice
-
Wu J, Liu L, Yen RD, Le HT, et al. 177 Polycationic liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology. 2004;40:195-204.
-
(2004)
Hepatology.
, vol.40
, pp. 195-204
-
-
Wu, J.1
Liu, L.2
Yen, R.D.3
Le, H.T.4
-
33
-
-
34547380021
-
Pharmacokinetics and biodistribution of 3H-norcantharidin in mice
-
Wei CM, Wang BJ, Ma Y, Sun ZP, Li XL, Guo RC. Pharmacokinetics and biodistribution of 3H-norcantharidin in mice. Acta Pharmaceutica Sinica. 2007;42(5):516-519.
-
(2007)
Acta Pharmaceutica Sinica.
, vol.42
, Issue.5
, pp. 516-519
-
-
Wei, C.M.1
Wang, B.J.2
Ma, Y.3
Sun, Z.P.4
Li, X.L.5
Guo, R.C.6
|